Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder [Phase 1]
Phase 1 study evaluating RO4917838 on biomarker measures of cognitive dysfunction in participants with schizophrenia and schizoaffective dis…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of RO5545965 in schizophrenia patients taking risperidone has comple…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia [Phase 2]
Phase 2 study of RO4917838 (Bitopertin) in patients with acute exacerbation of schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) [Phase 3]
Phase 3 trial of Bitopertin (RO4917838) in schizophrenia has completed. The update reports the study status without detailing results.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) [Phase 3]
Phase 3 clinical trial update for Bitopertin (RO4917838) in patients with persistent, predominant negative symptoms of schizophrenia; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: tDCS & Auditory Hallucinations in Schizophrenia [NA]
This clinical trial update reports termination of a study evaluating transcranial direct current stimulation for auditory hallucinations in …
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia
A completed non-interventional study evaluating patients with persistent symptoms of schizophrenia, sponsored by Hoffmann-La Roche.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305) [Phase 3]
This update describes a Phase 3 study of bitopertin (RO4917838) for sub-optimally controlled schizophrenia symptoms. The trial status is com…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
A completed non-interventional study sponsored by Hoffmann-La Roche describes medical resource utilization and burden of illness in patients…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: The Management of Schizophrenia in Clinical Practice (MOSAIC)
The MOSAIC clinical trial, sponsored by Genentech, studying the management of schizophrenia in clinical practice has completed. The study is…
-
FDA approval · 2016-11-01FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original application for quetiapine fumarate, granting marketing authorization for a generic versi…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Specialized Treatment Early in Psychosis (STEP) [NA]
This document reports a completed STEP trial evaluating specialized treatment early in psychosis, with results posted in 2016. The study foc…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Cognitive Behavior Therapy and Work Outcome [NA]
A completed trial assessed cognitive behavior therapy and work outcomes in schizophrenia, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants [Phase 1]
Phase 1 safety, tolerability and pharmacokinetic study of TAK-063 in participants with stable schizophrenia and healthy volunteers has compl…
-
FDA approval · 2016-10-27FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) by Eli Lilly and Company, resulting in updated labeling t…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: CHANGE -it is About Life [Phase 3]
A Phase 3 clinical trial named CHANGE - it is About Life has completed. It covers schizophrenia and metabolic syndrome.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) [Phase 3]
A long-term safety Phase 3 study of ALKS 9072/ALKS 9070 in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Effect of Repetitive Transcranial Magnetic Stimulation on Resting State Brain Activity in Schizophrenia [NA]
A completed clinical trial evaluated the effect of repetitive transcranial magnetic stimulation on resting-state brain activity in individua…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen [NA]
This update notes the completed status of a substudy within the OPTIMISE trial at Copenhagen, focusing on optimization of treatment and mana…
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia [Phase 4]
Phase 4 trial evaluating valacyclovir augmentation for cognitive and functional remediation in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Extended Specialized Assertive Intervention for First Episode Psychosis [NA]
The University of Copenhagen reports completion of a trial evaluating an extended specialized assertive intervention for individuals with fi…
-
FDA approval · 2016-10-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for aripiprazole from Torrent Pharmaceuticals Limited, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation [Phase 4]
Phase 4 trial evaluating the efficacy and safety of three days of intramuscular ziprasidone in patients with psychotic agitation associated …
-
FDA approval · 2016-10-17FDA Approved: PERPHENAZINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic Perphenazine (perphenazine) under an original ANDA (ANDA207582), marking its first approval as a gener…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety, Blood Levels and Effects of AUT00206 [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics (blood levels), and pharmacodynamic effects of AUT00206 in schizophrenia; the trial ha…